Zombie health care news

Although I am advancing rapidly into almost complete retirement, there are some days/weeks when I can’t refrain from pointing out some of the troubling health care news I see.  This is one such week. First, the COVID zombie news My local Star Tribune newspaper delivered this front page news: University of Minnesota, Mayo report COVID-fighting success… Read More »

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia. “We are… Read More »

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.–(BUSINESS WIRE)–Jun. 10, 2021– Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the pediatric indication of Epclusa (sofosbuvir/velpatasvir) for the treatment of chronic hepatitis C virus (HCV) to now include children as young as 3 years of age, regardless of HCV… Read More »